Carvedilol Tablet, Film Coated
Product Images NDC 68788-7539

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 68788-7539). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)

Chemical structure diagram of Carvedilol, showing its molecular configuration with hydroxy, methoxy groups, and aromatic rings as labeled in the image.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)

A line graph showing cumulative mortality percentage over 21 months comparing Carvedilol treatment to placebo. The graph plots % mortality on the vertical axis against time in months on the horizontal axis, with Carvedilol showing lower mortality rates than placebo throughout the period.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)

A horizontal forest plot illustrating hazard ratios across various patient subgroups including sex, age, race, diabetic status, ischemic condition, heart rate, systolic blood pressure, and use of spironolactone. Each subgroup is marked with a point estimate and confidence interval, visually comparing relative risk values around a vertical reference line at 1.0.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)

A line graph comparing mortality percentages over 24 months between patients treated with Carvedilol and a placebo. The x-axis shows time in months, and the y-axis shows percentage mortality up to 30%. The graph highlights a statistically significant difference (P = 0.03) favoring Carvedilol over placebo.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)

A forest plot showing hazard ratios for different patient subgroups related to myocardial infarction (MI) and congestive heart failure (CHF). The plot compares randomized patients at various days post-MI, prior use of beta-blockers, Killip classes, thrombolytic therapy status, use of PTCA for MI, age, sex, presence of CHF, use of diuretics, angina status, hypertension, diabetes, heart rate, and systolic blood pressure. Each subgroup has a corresponding hazard ratio with confidence intervals plotted on a horizontal scale from 0.4 to 1.3.*

FDA Label Image

Carvedilol Tablets 12.5mg (B1fa8af3 9789 45d2 8b77 A53935c52b49 06)

Carvedilol Tablets, 12.5 mg film-coated tablets label from Preferred Pharmaceuticals, Inc. The label highlights the dosage strength and states it as a generic for Coreg. It includes dosing instructions in English and Spanish, storage warnings, manufacturer details (Zydus Pharmaceuticals USA Inc.), and a federal caution against drug transfer. The label features a barcode and a QR code on a yellow background section.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.